The medical community welcomed a budget deal struck Tuesday night by the U.S. Congress, which, if approved, would restore funding to the National Institutes of Health, among other federal programs, that had been slashed under sequestration earlier this year.
Scientists believe that for the first time, they have linked the gene CUX1 to the development of one in every 100 tumors in cancer patients.
International Stem Cell Corp. has found a new way to genetically reprogram mature cells into an embryonic-like state, a technique the Carlsbad, CA-based company believes is a safer and more efficient way of creating induced pluripotent stem cells.
A gene discovery by researchers at Tel Aviv University may predict which people are likely to benefit from commonly prescribed antidepressants known as selective serotonin reuptake inhibitors.
With resistance to first-line malaria drugs and the emergence of an especially severe form of malaria on the rise, more investment in early science is needed to combat the disease, according to a new report.
GlaxoSmithKline is launching what it calls the Oncology Clinical and Translational Consortium, a collaborative scientific research network intended to advance drug discovery that will include 6 cancer centers around the world.
Stem cell technology developer Cellular Dynamics said Wednesday it will collaborate with the nonprofit Jain Foundation to create induced pluripotent stem cell lines from patients with certain genetic muscular dystrophies in an effort to find stem cell-based therapies for these disorders.
For decades, scientists have been trying to find potential drugs to serve as male contraceptives to no avail. Now, a new male contraceptive could finally be within grasp with the discovery of a dual protein linked to sperm ejaculation.
The National Institutes of Health said Monday that it has made available for researchers the first batch of genome sequence data from the Alzheimer's Disease Sequencing Project.
Novartis scientists, in collaboration with an international team of researchers from the University of California, San Diego, and Columbia University, have identified a novel drug target for treating malaria, a scourge of many tropical Third World countries.
In a discovery that could put a vaccine for hepatitis C closer in sight, researchers have been able to characterize a key protein in the virus that aids infection in the liver.
Writing in a recent issue of Nature, Dr. Benjamin Haibe-Kains of the Institut de Recherches Cliniques de Montréal says that additional standardization to improve the reproducibility of drug screening studies is needed.
The Obama administration announced Monday afternoon that the National Institutes of Health will redirect $100 million in funding to establish a new program to find better treatments--and eventually, a cure--for HIV and AIDS.
The environment that exists inside a person's intestines may impact the effectiveness of cancer therapy, according to new research by investigators at the National Cancer Institute and France's Gustave Roussy Institute.
In an effort to better understand diseases that have long eluded diagnosis, the New York Stem Cell Foundation Research Institute is partnering with the National Institutes of Health's Undiagnosed Diseases Program to create cell models of rare medical conditions.
Using RNA interference technology, scientists have discovered a network of genes that could serve as new therapeutic targets for Parkinson's disease as well as other diseases characterized by mitochondrial damage.
Amidst a challenging R&D environment, Atlanta-based Biota Pharmaceuticals has dumped its preclinical antibiotics program, saying that it will continue to seek out licensing agreements and other deals to advance the development of its candidates.
Eli Lilly and the nonprofit Project A.L.S. are teaming up to boost the pipeline of potential drugs for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig' disease.
A DNA vaccine developed by Blue Bell, PA-based Inovio Pharmaceuticals induced robust and durable immune responses against the deadly MERS coronavirus in a preclinical model.
Austrian researchers have discovered a compound that may be able to activate a protein in the body to trigger fat burning.